Few neurological diseases are as challenging as amyotrophic lateral sclerosis (ALS), a progressive condition that damages nerve cells responsible for movement. At Johns Hopkins University, Dr. Nicholas Maragakis has spent much of his career working to better understand ALS and develop new approaches that could eventually lead to improved treatments.
Dr. Maragakis is a Professor of Neurology at Johns Hopkins University School of Medicine, Director of the Johns Hopkins ALS Center for Cell Therapy and Regeneration Research, and Co-Director of the Johns Hopkins ALS Clinic. His work combines patient care with laboratory research aimed at understanding how ALS develops and progresses.
A particularly important part of his research involves understanding the role of cells surrounding motor neurons. His laboratory has investigated astrocytes and other glial cells, which were once viewed primarily as supporting cells but are increasingly understood to play important roles in neurological disease.
Maragakis and his colleagues have also used induced pluripotent stem cells (iPSCs) derived from ALS patients. These cells can be transformed into different types of human cells, giving researchers a way to study disease mechanisms in laboratory models that more closely reflect human biology. His laboratory helped create stem cell lines from ALS patients as part of this research effort.
This work is particularly significant because ALS has historically been difficult to study. Researchers need to understand not only what happens to motor neurons, but also why surrounding cells may contribute to their deterioration. Maragakis’ research has examined how astrocytes may influence the spread and progression of ALS and whether these pathways could become targets for future therapies.
His research program is also closely connected to clinical trials. As Medical Director of the Johns Hopkins ALS Clinical Trials Unit, Maragakis helps connect laboratory discoveries with the development and evaluation of potential therapies. The Johns Hopkins ALS Center’s broader mission is to identify the causes of ALS and discover new treatment options for patients.
In addition to his research, Maragakis has spent more than two decades caring for patients with ALS. That combination of clinical experience and laboratory investigation gives his work a particularly practical focus: discoveries made in the laboratory ultimately need to translate into meaningful improvements for people living with the disease.
Recent educational and research activities have continued to highlight his work on the cells and biological pathways involved in ALS. His laboratory remains interested in stem-cell-derived motor neurons and glial cells, as well as potential therapeutic compounds that could interfere with disease progression.
Dr. Maragakis represents an important part of modern medicine in which physicians are not only treating established diseases but also trying to understand them at a cellular level. His combination of specialized patient care, stem-cell research and clinical-trial leadership is helping advance the search for better options for people living with ALS.
As scientists continue to investigate the complex biological mechanisms behind neurodegenerative disease, the work being carried out at Johns Hopkins offers hope that a deeper understanding of ALS can eventually lead to more targeted and effective therapies.
